These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
44. Cessation versus continuation of galantamine treatment after 12 months of therapy in patients with Alzheimer's disease: a randomized, double blind, placebo controlled withdrawal trial. Scarpini E; Bruno G; Zappalà G; Adami M; Richarz U; Gaudig M; Jacobs A; Schäuble B J Alzheimers Dis; 2011; 26(2):211-20. PubMed ID: 21606568 [TBL] [Abstract][Full Text] [Related]
45. [The influence of cerebrolysin on the efficiency of subsequent therapy with amiridine++ in Alzheimer's disease patients (neuropsychological investigation)]. Roshchina IF; Kolykhalov IV; Selezneva ND; Zharikov GA; Gerasimov NP; Gavrilova SI Zh Nevrol Psikhiatr Im S S Korsakova; 1999; 99(12):43-6. PubMed ID: 10629930 [TBL] [Abstract][Full Text] [Related]
46. Neuroprotective treatment with cerebrolysin in patients with acute stroke: a randomised controlled trial. Ladurner G; Kalvach P; Moessler H; J Neural Transm (Vienna); 2005 Mar; 112(3):415-28. PubMed ID: 15583955 [TBL] [Abstract][Full Text] [Related]
47. Efficacy and safety of donepezil over 3 years: an open-label, multicentre study in patients with Alzheimer's disease. Burns A; Gauthier S; Perdomo C Int J Geriatr Psychiatry; 2007 Aug; 22(8):806-12. PubMed ID: 17199235 [TBL] [Abstract][Full Text] [Related]
48. Evaluating rivastigmine in mild-to-moderate Parkinson's disease dementia using ADAS-cog items. Schmitt FA; Aarsland D; Brønnick KS; Meng X; Tekin S; Olin JT Am J Alzheimers Dis Other Demen; 2010 Aug; 25(5):407-13. PubMed ID: 20392860 [TBL] [Abstract][Full Text] [Related]
50. Rationale and design of a multicenter, phase 2 clinical trial to investigate the efficacy of traditional Chinese medicine SaiLuoTong in vascular dementia. Liang J; Li F; Wei C; Song H; Wu L; Tang Y; Jia J J Stroke Cerebrovasc Dis; 2014; 23(10):2626-2634. PubMed ID: 25294055 [TBL] [Abstract][Full Text] [Related]
51. Meta-analysis: the efficacy of nootropic agent Cerebrolysin in the treatment of Alzheimer's disease. Wei ZH; He QB; Wang H; Su BH; Chen HZ J Neural Transm (Vienna); 2007; 114(5):629-34. PubMed ID: 17318304 [TBL] [Abstract][Full Text] [Related]
52. Donepezil treatment of patients with MCI: a 48-week randomized, placebo-controlled trial. Doody RS; Ferris SH; Salloway S; Sun Y; Goldman R; Watkins WE; Xu Y; Murthy AK Neurology; 2009 May; 72(18):1555-61. PubMed ID: 19176895 [TBL] [Abstract][Full Text] [Related]
53. Cognitive, global, and functional benefits of donepezil in Alzheimer's disease and vascular dementia: results from large-scale clinical trials. Passmore AP; Bayer AJ; Steinhagen-Thiessen E J Neurol Sci; 2005 Mar; 229-230():141-6. PubMed ID: 15760632 [TBL] [Abstract][Full Text] [Related]
54. Efficacy of the peptidergic nootropic drug cerebrolysin in patients with senile dementia of the Alzheimer type (SDAT). Rüther E; Ritter R; Apecechea M; Freytag S; Windisch M Pharmacopsychiatry; 1994 Jan; 27(1):32-40. PubMed ID: 8159781 [TBL] [Abstract][Full Text] [Related]
55. Spotlight on cerebrolysin in dementia. Plosker GL; Gauthier S CNS Drugs; 2010 Mar; 24(3):263-6. PubMed ID: 20155999 [TBL] [Abstract][Full Text] [Related]
57. Clinical correlates of cognitive decline in vascular dementia. Paul RH; Cohen RA; Moser DJ; Ott BR; Sethi M; Sweet L; Browndyke J; Malloy P; Garrett K Cogn Behav Neurol; 2003 Mar; 16(1):40-6. PubMed ID: 14765000 [TBL] [Abstract][Full Text] [Related]
58. Efficacy and safety of cerebrolysin in neurorecovery after moderate-severe traumatic brain injury: results from the CAPTAIN II trial. Muresanu DF; Florian S; Hömberg V; Matula C; von Steinbüchel N; Vos PE; von Wild K; Birle C; Muresanu I; Slavoaca D; Rosu OV; Strilciuc S; Vester J Neurol Sci; 2020 May; 41(5):1171-1181. PubMed ID: 31897941 [TBL] [Abstract][Full Text] [Related]
59. Improved global function and activities of daily living in patients with AD: a placebo-controlled clinical study with the neurotrophic agent Cerebrolysin. Muresanu DF; Rainer M; Moessler H J Neural Transm Suppl; 2002; (62):277-85. PubMed ID: 12456070 [TBL] [Abstract][Full Text] [Related]
60. The serial position effect in mild and moderately severe vascular dementia. Paul RH; Cohen RA; Moser DJ; Zawacki TM; Gordon N J Int Neuropsychol Soc; 2002 May; 8(4):584-7. PubMed ID: 12030311 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]